Second Quarter of Fiscal Year Ended Mar. 2022
- Key metrics （PDF / 308KB）
- Composition of Capital Disclosure （PDF / 145KB）
- Reconciliation of regulatory capital to the balance sheet （PDF / 44KB）
- Overview of RWA （PDF / 85KB）
- RWA flow statements of credit risk exposures under IRB （PDF / 23KB）
- RWA flow statements of market risk exposures under IMA （PDF / 24KB）
- Composition of Leverage Ratio （PDF / 144KB）
- Liquidity Coverage Ratio （PDF / 45KB）
- Net Stable Funding Ratio （PDF / 136KB）
- Main features of regulatory capital instruments
Regulatory capital instruments (TLAC eligible)
Eligible capital instruments under transitional treatment (not TLAC eligible (note))
- Can be counted in external and internal TLAC by 2022/3/30 as FSB's transitional treatment